Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. J. Bispecific T-Cell Engager>G > >4 Prior Lines of Therapy>

---

proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 Ab


>4 Prior Lines of Therapy>'s products
This section has no products